148 related articles for article (PubMed ID: 26617941)
1. Beta-3 adrenergic receptors could be significant factors for overactive bladder-related symptoms.
Yamamichi F; Shigemura K; Behnsawy HM; Yamashita M; Shirakawa T; Fujisawa M
Int J Clin Exp Pathol; 2015; 8(9):11863-70. PubMed ID: 26617941
[TBL] [Abstract][Full Text] [Related]
2. Correlation between improvements in Overactive Bladder Symptom Score and health-related quality of life questionnaires in overactive bladder patients treated with an antimuscarinic drug.
Kubota Y; Kojima Y; Shibata Y; Imura M; Kohri K; Sasaki S
Neurourol Urodyn; 2011 Sep; 30(7):1309-14. PubMed ID: 21560155
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the overactive bladder symptom score and the overactive bladder symptom score derived from the bladder diaries.
Hikita KS; Honda M; Hirano S; Kawamoto B; Panagiota T; Muraoka K; Sejima T; Takenaka A
Neurourol Urodyn; 2016 Mar; 35(3):349-53. PubMed ID: 25597478
[TBL] [Abstract][Full Text] [Related]
4. Correlation between overactive bladder symptoms and quality of life in Japanese male patients: focus on nocturia.
Takao T; Tsujimura A; Kiuchi H; Takezawa K; Okuda H; Yamamoto K; Fukuhara S; Miyagawa Y; Nonomura N
Urology; 2013 Jul; 82(1):189-93. PubMed ID: 23642937
[TBL] [Abstract][Full Text] [Related]
5. Reliability of Thai-Version Overactive Bladder Symptom Scores (OABSS) Questionnaire and the Correlations of OABSS with Voiding Diary, International Prostate Symptom Score (IPSS), and Patient Perception of Bladder Condition (PPBC) Questionnaires.
Bunyavejchevin S
J Med Assoc Thai; 2015 Nov; 98(11):1064-74. PubMed ID: 26817176
[TBL] [Abstract][Full Text] [Related]
6. The translation and validation of Chinese overactive bladder symptom score for assessing overactive bladder syndrome and response to solifenacin treatment.
Chou EC; Hung MJ; Yen TW; Chuang YC; Meng E; Huang ST; Kuo HC
J Formos Med Assoc; 2014 Aug; 113(8):506-12. PubMed ID: 25037757
[TBL] [Abstract][Full Text] [Related]
7. Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT Study.
Yamanishi T; Asakura H; Seki N; Tokunaga S
Urol Int; 2021; 105(9-10):817-825. PubMed ID: 33690238
[TBL] [Abstract][Full Text] [Related]
8. Test - retest reliability of the Indonesian version of the Overactive Bladder Symptom Score (OABSS) and its correlation with standard assessment tools.
Sumardi R; Mochtar CA; Junizaf ; Santoso BI; Tjahjodjati ; Purwara BH; Hardjowijoto S; Paraton H; Yunaidi DA
Acta Med Indones; 2012 Jul; 44(3):214-21. PubMed ID: 22983076
[TBL] [Abstract][Full Text] [Related]
9. Reliability of the Polish version of the Overactive Bladder Symptom Score (OABSS) questionnaire : Correlation of the OABSS with urodynamic study and the UDI-6 and IIQ-7 questionnaires.
Wróbel A; Skorupska K; Rechberger E; Woźniak A; Miotla P; Kubik-Komar A; Skorupski P; Rechberger T
Int Urogynecol J; 2019 Dec; 30(12):2135-2139. PubMed ID: 31396639
[TBL] [Abstract][Full Text] [Related]
10. Are patients with the symptoms of overactive bladder and urodynamic detrusor overactivity different from those with overactive bladder but not detrusor overactivity?
Fan YH; Lin CC; Lin AT; Chen KK
J Chin Med Assoc; 2011 Oct; 74(10):455-9. PubMed ID: 22036137
[TBL] [Abstract][Full Text] [Related]
11. Reliability and validity of the Overactive Bladder Symptom Score in Spanish (OABSS-S).
Weinberg AC; Brandeis GH; Bruyere J; Tsui JF; Weiss JP; Rutman MP; Blaivas JG
Neurourol Urodyn; 2012 Jun; 31(5):664-8. PubMed ID: 22488591
[TBL] [Abstract][Full Text] [Related]
12. Turkish validation of the overactive bladder symptom score (OABSS) and evaluation of mirabegron treatment response.
Culha MG; Degirmentepe RB; Ozbir S; Cakir SS; Homma Y
Int Urogynecol J; 2019 Dec; 30(12):2121-2126. PubMed ID: 31332467
[TBL] [Abstract][Full Text] [Related]
13. International Prostate Symptom Score for assessing lower urinary tract dysfunction in women.
Hsiao SM; Lin HH; Kuo HC
Int Urogynecol J; 2013 Feb; 24(2):263-7. PubMed ID: 22588143
[TBL] [Abstract][Full Text] [Related]
14. Characterization of symptom bother and health-related quality of life in Japanese female patients with overactive bladder.
Gotoh M; Kobayashi T; Sogabe K
Neurourol Urodyn; 2015 Nov; 34(8):730-5. PubMed ID: 25212503
[TBL] [Abstract][Full Text] [Related]
15. [Clinical efficacy of tolterodine for patients with overactive bladder after insufficient efficacy by monotherapy with alpha1-adrenoceptor antagonist].
Tsujimura A; Takao T; Uchida K; Yamamoto K; Fukuhara S; Nakayama J; Ueda T; Hirai T; Kiuchi H; Miyagawa Y; Takahashi T; Kojimaan Y; Okuyama A
Nihon Hinyokika Gakkai Zasshi; 2009 Nov; 100(7):686-92. PubMed ID: 19999133
[TBL] [Abstract][Full Text] [Related]
16. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
17. Overactive bladder symptom severity, bother, help-seeking behavior, and quality of life in patients with type 2 diabetes: a path analysis.
Xu D; Zhao M; Huang L; Wang K
Health Qual Life Outcomes; 2018 Jan; 16(1):1. PubMed ID: 29291738
[TBL] [Abstract][Full Text] [Related]
18. Symptom severity and patient perceptions in overactive bladder: how are they related?
Homma Y; Gotoh M
BJU Int; 2009 Oct; 104(7):968-72. PubMed ID: 19338560
[TBL] [Abstract][Full Text] [Related]
19. Interplay between bladder microbiota and overactive bladder symptom severity: a cross-sectional study.
Li K; Chen C; Zeng J; Wen Y; Chen W; Zhao J; Wu P
BMC Urol; 2022 Mar; 22(1):39. PubMed ID: 35305613
[TBL] [Abstract][Full Text] [Related]
20. Correlation between overactive bladder symptom score and neuropsychological parameters in Alzheimer's disease patients with lower urinary tract symptom.
Jung HB; Choi DK; Lee SH; Cho ST; Na HR; Park MH
Int Braz J Urol; 2017; 43(2):256-263. PubMed ID: 27802001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
